372 related articles for article (PubMed ID: 19282203)
1. Factors associated with poor glycemic control among patients with type 2 diabetes.
Khattab M; Khader YS; Al-Khawaldeh A; Ajlouni K
J Diabetes Complications; 2010; 24(2):84-9. PubMed ID: 19282203
[TBL] [Abstract][Full Text] [Related]
2. Depression among adults with diabetes in Jordan: risk factors and relationship to blood sugar control.
Al-Amer RM; Sobeh MM; Zayed AA; Al-Domi HA
J Diabetes Complications; 2011; 25(4):247-52. PubMed ID: 21601482
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan.
Al-Eitan LN; Nassar AM; Saadeh NA; Almomani BA
Can J Diabetes; 2016 Dec; 40(6):496-502. PubMed ID: 27212046
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated with Poor Hemoglobin A1c Control in Patients with Type 2 Diabetes.
Alqudah S; Jarab AS; Alefishat EA; Mayyas F; Khdour M; Pinto S
Curr Diabetes Rev; 2019; 15(2):164-170. PubMed ID: 29745337
[TBL] [Abstract][Full Text] [Related]
5. Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes.
Rothman RL; Mulvaney S; Elasy TA; VanderWoude A; Gebretsadik T; Shintani A; Potter A; Russell WE; Schlundt D
Pediatrics; 2008 Apr; 121(4):e912-9. PubMed ID: 18381520
[TBL] [Abstract][Full Text] [Related]
6. Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital.
Ayele AA; Tegegn HG; Ayele TA; Ayalew MB
BMJ Open Diabetes Res Care; 2019; 7(1):e000685. PubMed ID: 31321061
[TBL] [Abstract][Full Text] [Related]
7. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
[TBL] [Abstract][Full Text] [Related]
8. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
9. Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes.
Jang HN; Yang YS; Lee SO; Oh TJ; Koo BK; Jung HS
Endocrinol Metab (Seoul); 2019 Dec; 34(4):382-389. PubMed ID: 31884738
[TBL] [Abstract][Full Text] [Related]
10. Biophysiologic outcomes of the Enhancing Adherence in Type 2 Diabetes (ENHANCE) trial.
Sevick MA; Korytkowski M; Stone RA; Piraino B; Ren D; Sereika S; Wang Y; Steenkiste A; Burke LE
J Acad Nutr Diet; 2012 Aug; 112(8):1147-57. PubMed ID: 22818724
[TBL] [Abstract][Full Text] [Related]
11. Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study.
Borgharkar SS; Das SS
BMJ Open Diabetes Res Care; 2019; 7(1):e000654. PubMed ID: 31413840
[TBL] [Abstract][Full Text] [Related]
12. Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south west Ethiopia: a case control study.
Mamo Y; Bekele F; Nigussie T; Zewudie A
BMC Endocr Disord; 2019 Aug; 19(1):91. PubMed ID: 31464602
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Lauffenburger JC; Lewey J; Jan S; Makanji S; Ferro CA; Krumme AA; Lee J; Ghazinouri R; Haff N; Choudhry NK
JAMA Netw Open; 2019 Mar; 2(3):e190657. PubMed ID: 30874782
[TBL] [Abstract][Full Text] [Related]
14. Medication adherence and associated hemoglobin A1c in type 2 diabetes.
Krapek K; King K; Warren SS; George KG; Caputo DA; Mihelich K; Holst EM; Nichol MB; Shi SG; Livengood KB; Walden S; Lubowski TJ
Ann Pharmacother; 2004 Sep; 38(9):1357-62. PubMed ID: 15238621
[TBL] [Abstract][Full Text] [Related]
15. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
16. Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes: Empowerment Perceptions and Diabetes Distress as Important Determinants.
Chen SY; Hsu HC; Wang RH; Lee YJ; Hsieh CH
Biol Res Nurs; 2019 Mar; 21(2):182-189. PubMed ID: 30585081
[TBL] [Abstract][Full Text] [Related]
17. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
Wishah RA; Al-Khawaldeh OA; Albsoul AM
Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
[TBL] [Abstract][Full Text] [Related]
18. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Glycemic Control among Patients with Type 2 Diabetes in Western China: A Multi-center Cross Sectional Study.
Xiang Y; Ren B; Chen Y; Jiang M; Wang N; Niu R; Feng B
Biol Pharm Bull; 2021; 44(5):620-626. PubMed ID: 33952818
[TBL] [Abstract][Full Text] [Related]
20. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Kennedy L; Herman WH; Strange P; Harris A;
Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
